All NAD+ Protocols
Post-viral cellular recovery

LathMized™ NAD+
Post-Viral Recovery

If you've had COVID — or any serious viral illness — and you haven't felt right since, you're not imagining it. Post-viral NAD+ depletion is one of the most well-documented metabolic consequences of infection. The fatigue, the brain fog, the feeling that your body won't respond the way it used to — these trace back to a cellular energy deficit that rest alone won't fix.

3-Phase Protocol Practitioner Supervised RCT Backed Most Intensive Protocol
53%
Intracellular NAD+
increase · 5 days
100%
Participants
responded
87
Biomarkers
significantly changed
0
Serious adverse
events recorded
This protocol is designed for

Does this sound like you?

You still don't feel like yourself months after COVID — the fatigue, brain fog or breathlessness that was supposed to pass hasn't. That's Long COVID, and NAD+ depletion is a central part of the metabolic picture.
You were ill, you recovered — except you didn't fully — weeks or months later you're still running at 60%. The illness itself passed but your energy didn't come back with it.
Your immune system seems stuck in 'on' mode — chronic low-grade inflammation, unusual symptoms, a body that feels like it's still fighting something. Post-viral immune dysregulation depletes NAD+ significantly.
Any exertion sends you backwards — a walk, a call, a morning of activity — and you spend the next day paying for it. PEM is one of the most debilitating features of Long COVID and it points directly to mitochondrial dysfunction.
You've tried everything your GP has suggested — rest, pacing, graded exercise, supplements — and you're still not where you were. You're looking for something that works at the root cause.
You want a structured recovery plan, not random things to try — a proper programme with clinical backing, practitioner guidance, and a clear path from where you are now to where you want to be.
What this protocol supports

What this actually does

All claims are based on statistically significant biomarker changes from the RENEWAL-NAD+ placebo-controlled double-blind RCT (NCT07336836).

Mitochondrial Energy Restoration
The fatigue of Long COVID isn't ordinary tiredness. It's your cells running on empty. NAD+ is the cofactor that makes mitochondrial ATP production work. Phase 1 floods depleted stores with the most intensive NAD+ repletion schedule in the Harmover range.
Brain Fog & Cognitive Clarity
The RENEWAL-NAD+ trial showed significant upregulation of neuroprotective proteins, serotonin signalling markers, and microglial health indicators — the biology behind clearer thinking, better word recall, and reduced mental fatigue.
Post-Exertional Malaise (PEM)
As NAD+ is restored and mitochondrial function improves, the cellular basis for PEM diminishes. Most members don't go from PEM to running — but the threshold for crashing gets higher and recovery becomes faster.
Immune Dysregulation
The RENEWAL-NAD+ trial showed significant downregulation of inflammation-associated proteins. For post-viral immune dysregulation — where the immune system hasn't returned to baseline — this is one of the most relevant findings.
Oxidative DNA Repair
The oxidative damage from a serious viral infection affects your DNA. NAD+-dependent PARP activity drives the repair of that damage. Without adequate NAD+, the repair backlog compounds — contributing to the sense that your body simply isn't functioning at full capacity.
Systemic Energy Recovery
SARS-CoV-2 directly consumes NAD+ during replication and activates PARP enzymes that deplete it further. LathMized™ delivers NAD+ directly to cells, bypassing conversion pathways that may also be compromised post-infection.

All benefits listed reflect statistically significant biomarker changes from the RENEWAL-NAD+ placebo-controlled double-blind RCT (NCT07336836) — conducted with the Institute of Systems Biology and published on bioRxiv 2026. Peer review pending.

Your membership includes

What's included

Every element of this protocol — including the full dosing schedule, product supply and practitioner support — is available exclusively to Harmover members.

Practitioner Assessment
Post-viral syndromes are complex and individual. A Harmover practitioner reviews your symptom history, COVID timeline, and current health picture before approving this protocol.
Full 3-Phase Protocol Access
Once approved, your full 3-phase protocol document is released in your dashboard — detailed guidance for each phase in plain language, with check-in points throughout your recovery.
All Three Phase Products
Phase 1 and 2 use LathMized™ powder at different intensities; Phase 3 transitions to sublingual tablets for long-term daily maintenance. All shipped after purchase.
Enhanced Practitioner Support
This is our most closely supported protocol. Check-ins are built in at higher frequency given the complexity of post-viral recovery, and your practitioner is available throughout via direct messaging.
Purchase options

Get the products for this protocol

Both products require member registration and practitioner approval before purchase.

Complete bundle Best Value
Complete Long COVID & Post-Viral Kit
Powder + Tablets — all phases

All phase products together — powder for the 5-day intensive repletion and 20-day intermediate maintenance, sublingual tablets for ongoing daily maintenance. Includes your full protocol document, monitoring guidance, and practitioner support.

All 3 phases included Maintenance Tablets included Practitioner support included
Register to Purchase Bundle

Free registration · No commitment

Or purchase by phase individually
LathMized NAD+ Powder — Phase 1 Post-Viral Protocol — 2,000mg daily high-intensity repletion
Phases 1 & 2 · Repletion + Intermediate
LathMized™ NAD+ Powder

Phase 1: 2,000mg/day in four divided doses for 5 days — the highest intensity in the Harmover range, targeting the severe NAD+ depletion of post-viral syndromes. Phase 2 continues at 250mg/day for 20 days.

Protocol dose
2,000mg/day · QID · Days 1–5
250mg/day · AM · Days 6–25
Register to Purchase
LathMized NAD+ Sublingual Tablets — Phase 3 Post-Viral Protocol — long-term daily maintenance
Phase 3 · Long-Term Maintenance
LathMized™ NAD+ Sublingual Tablets

Used from Day 26 onwards — 100mg sublingual tablet placed under the tongue each morning. Sustains the NAD+ levels restored across Phases 1 and 2, month after month.

Protocol dose
100mg/day · AM · Day 26+
Register to Purchase
Members only

How to get started

Registration is free and takes less than two minutes. A Harmover practitioner reviews your health summary before releasing your personalised protocol access.

Register free — takes under 2 minutes. We ask for basic health information so your practitioner review is meaningful, not a formality
Practitioner review — usually within 24–48 hours. They're checking this protocol is a good fit for you specifically
You're in — your full protocol document is unlocked, your products are shipped, and your practitioner support is live
Long COVID & Post-Viral
LathMized™ NAD+ Long COVID & Post-Viral Recovery Protocol
Your membership includes
  • Practitioner Assessment
  • Full 3-Phase Protocol Access
  • All Three Phase Products
  • Enhanced Practitioner Support

Register Free — Get Started

Free to register · No commitment · Ships UK · EU · US · Canada

Clinical evidence

Backed by a double-blind RCT

The RENEWAL-NAD+ study — conducted with the Institute of Systems Biology, approved by Western IRB (Protocol No. 20215675) — provides the clinical foundation for the LathMized™ platform.

"In a placebo-controlled double-blind trial specifically relevant to the metabolic mechanisms of post-viral syndromes, LathMized™ NAD+ raised intracellular NAD+ levels by 53% in five days. Blood plasma NAD+ was unchanged — confirming cellular delivery. Every participant responded. SIRT1 increased by 32%. Nine of the twelve hallmarks of ageing were positively affected. Zero serious adverse events."

RENEWAL-NAD+ RCT · NCT07336836 · bioRxiv 2026 · DOI: 10.64898/2026.03.25.714130
RENEWAL-NAD+ RCT · NCT07336836 · bioRxiv 2026 Read preprint ↗ ClinicalTrials.gov ↗
53%
Intracellular NAD+
increase · 5 days
100%
Participants
responded
87
Biomarkers
significantly changed
0
Serious adverse
events recorded
Common questions

Questions about the Long COVID & Post-Viral Protocol

Is this suitable if I'm still experiencing active Long COVID symptoms?
Yes — this protocol was specifically designed for people in the Long COVID recovery phase, including those still experiencing persistent symptoms. Your practitioner will assess your current functional capacity and symptom severity before approving. If you are in an acute deterioration period, they may advise waiting before starting Phase 1. The protocol is not a crisis intervention — it's a structured recovery programme.
Why is Phase 1 only 5 days when other protocols are longer?
The Post-Viral Protocol uses the highest per-day dose in the Harmover range — 2,000mg/day in four divided doses. This intensive 5-day window reflects the severity of NAD+ depletion in post-viral syndromes and mirrors the most intensive clinical approach used in the physician protocol data. Phase 2 then steps down to 250mg/day over 20 days before transitioning to tablets.
What is post-exertional malaise (PEM) and can this help?
PEM is the worsening of symptoms after physical or cognitive exertion — a hallmark of Long COVID and ME/CFS. It reflects mitochondrial dysfunction: cells can't produce enough ATP to meet energy demands. As NAD+ is restored and mitochondrial function improves, the cellular basis for PEM diminishes. Most members find the threshold for crashing gradually rises — recovery doesn't happen overnight, but the trajectory changes.
Can I take this if I'm also on Long COVID clinic treatment?
Yes — this is a nutritional supplement, not a competing medical treatment. Please disclose it to your Long COVID clinic or specialist. Your Harmover practitioner will review your existing treatments and medications as part of the assessment. We recommend transparency with all your care providers throughout the programme.
How long before I notice changes?
Given the severity of NAD+ depletion in post-viral cases, Phase 1's intensive approach can produce noticeable shifts in energy within the first week for some members. Brain fog improvements are commonly reported in weeks 2–4. PEM threshold changes are slower — typically meaningful at 60–90 days. Recovery from Long COVID is non-linear; progress is real but rarely straightforward.
What is the difference between buying products individually versus as a bundle?
The individual option lets you purchase Phase 1 and 2 Powder and Phase 3 Tablets separately — useful for reordering mid-protocol. The bundle includes all phase products and is the best option for new members starting the full programme. All purchases require registration and practitioner approval.
Is this a prescription product?
LathMized™ NAD+ is a dietary supplement — not a prescription product. Harmover's practitioner review is built into membership because the Post-Viral Protocol is the most intensive in the Harmover range and appropriate clinical oversight matters. You register free, a practitioner reviews your case, and they may ask follow-up questions before approving — this is normal for this protocol specifically.
Important information

Before you begin

Please read

This protocol is a nutritional adjunct — not a treatment for Long COVID or any post-viral condition. It is designed to address a documented nutritional deficiency of NAD+ in individuals with post-viral syndromes, as an addition to — not replacement for — your existing medical care. Please continue all consultations with your GP or specialist and ensure they know you are following this programme.

Ready to begin?

Ready to start your recovery properly?

Long COVID recovery is not linear and it's not fast. But addressing the NAD+ deficit at its root — with a structured, supervised programme — gives you the best cellular foundation for genuine recovery.

Free to register · No commitment · Ships UK · EU · US · Canada

Reviewed by
Harmover Wellness Coach Team  ·  April 2026